View Older Stories

Jun 2, 2026 08:33AM Kura Oncology publishes ziftomenib combination study in Blood journal

May 28, 2026 05:21AM Kura Oncology (KURA) Reiterated at Market Outperform by Citizens on FIT-001 Data Preview

May 26, 2026 06:02AM KURA reports tumor shrinkage in 77% of patients in drug combination trial

May 13, 2026 05:48AM Kura Oncology (KURA) Reiterated at Market Outperform by Citizens After Q1 Results

May 12, 2026 04:02PM Kura Oncology (KURA) Reports In-Line Q1 EPS

Apr 17, 2026 06:00AM Kura Oncology reports darlifarnib plus cabozantinib shows activity in kidney cancer

Apr 14, 2026 07:24AM Lake Street Starts Kura Oncology (KURA) at Buy

Mar 24, 2026 10:58AM Kura Oncology (KURA) PT Lowered to $25 at Mizuho

Mar 13, 2026 09:55AM Kura Oncology (KURA) PT Lowered to $15 at UBS

Mar 6, 2026 04:49AM Kura Oncology (KURA) Reiterated at Market Outperform by Citizens After Q4 Results

Mar 5, 2026 06:32AM Kura Oncology (KURA) Misses Q4 EPS by 66c

Feb 2, 2026 04:46AM Kura Oncology (KURA) Reiterated at Market Outperform by Citizens on 2026 Outlook

Jan 12, 2026 04:07AM Kura Oncology reports $2.1 million in KOMZIFTI revenue for first weeks

Dec 9, 2025 05:17AM Kura Oncology's (KURA) Zifto a Therapeutic Partner to FLT-3 Inhibitors - Citizens

Dec 8, 2025 10:30AM Kura Oncology reports combination trial data for KOMZIFTI with venetoclax

Dec 5, 2025 05:26AM Kura Oncology's (KURA) Zitfo Has Meaningful Edge - Citizens

Nov 25, 2025 05:19PM KOMZIFTI added to NCCN guidelines for relapsed AML treatment

Nov 20, 2025 04:02AM Jefferies Reiterates Buy Rating on Kura Oncology (KURA)

Nov 14, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on Kura Oncology (KURA)

Nov 13, 2025 04:07PM Kura Oncology (KURA) PT Raised to $25 at Leerink Partners

Nov 13, 2025 10:15AM Kura Oncology receives FDA approval for blood cancer drug

Nov 13, 2025 10:02AM Kura Oncology (KURA) halted, news pending

Nov 4, 2025 06:35AM Kura Oncology (KURA) Misses Q3 EPS by 10c

Nov 3, 2025 04:02PM Kura Oncology receives $30 million milestone from Kyowa Kirin partnership

Nov 3, 2025 09:15AM Kura Oncology and Kyowa Kirin to present ziftomenib data at ASH meeting

Oct 27, 2025 04:19AM Kura Oncology (KURA) Shares Could Go Higher After AML Drug Approval Says Citizens

Oct 24, 2025 07:03AM Kura Oncology receives $30 million milestone from Kyowa Kirin partnership

Oct 20, 2025 09:49AM Citizens Highlights Kura Oncology’s (KURA) KO-2806 Potential, Reiterates at Outperform

Oct 20, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Kura Oncology (KURA)

Oct 2, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Kura Oncology (KURA)

Oct 1, 2025 07:01AM Kura Oncology and Kyowa Kirin begin trial combining cancer drugs for AML

Sep 30, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on Kura Oncology (KURA)

Sep 30, 2025 04:04AM Citizens JMP Reiterates Market Outperform Rating on Kura Oncology (KURA)

Sep 25, 2025 05:19PM Kura Oncology publishes ziftomenib trial data in oncology journal

Sep 17, 2025 04:15AM Citizens JMP Reiterates Market Outperform Rating on Kura Oncology (KURA)

Sep 16, 2025 04:01PM Kura Oncology presents preclinical data on drug combination therapy

Sep 4, 2025 05:44AM Guggenheim Starts Kura Oncology (KURA) at Neutral

Aug 11, 2025 04:07AM Kura Oncology (KURA) PT Lowered to $24 at Citizens JMP

Aug 7, 2025 04:15PM Kura Oncology (KURA) Misses Q2 EPS by 34c

Jun 27, 2025 07:15AM Cantor Fitzgerald Reiterates Overweight Rating on Kura Oncology (KURA)

Jun 26, 2025 07:02AM Cantor Fitzgerald Reiterates Overweight Rating on Kura Oncology (KURA)

Jun 20, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Kura Oncology (KURA)

Jun 13, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Kura Oncology (KURA)

Jun 13, 2025 05:29AM Citizens JMP Reiterates Market Outperform Rating on Kura Oncology (KURA)

Jun 12, 2025 07:31AM Kura Oncology (KURA) and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress

Jun 4, 2025 04:29AM Citizens JMP Reiterates Market Outperform Rating on Kura Oncology (KURA)

Jun 3, 2025 07:39AM Leerink Partners Reiterates Outperform Rating on Kura Oncology (KURA)

Jun 3, 2025 07:13AM Cantor Fitzgerald Reiterates Overweight Rating on Kura Oncology (KURA)

Jun 2, 2025 06:01PM Kura Oncology (KURA) and Kwoya Kirin announce positive Ziftomenib data

Jun 2, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on Kura Oncology (KURA)

View Older Stories